Arca
Skip to content
Tools
Tools

Bgm Galectin -3

Galectin-3 In Vitro Diagnostic Assay. 510(k) K093758, from Bg Medicine, Inc. (Waltham, MA). Product code OSX, class 2.

As of Nov 18, 2026, K093758 is an FDA 510(k) held by Bg Medicine, Inc., substantially equivalent on Nov 17, 2010 after 345 days, with no recalls tied to it in FDA's recall database.

  • Review time: 345 days
  • Recalls: 0
  • Cited as a predicate by: 2 devices

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

BGM Galectin-3 is an in vitro diagnostic device that quantitatively measures galectin-3 in serum or EDTA-plasma by enzyme linked immunosorbant assay (ELISA) on a microtiter plate platform. BGM Galectin-3 is indicated for use in conjunction with clinical evaluation as an aid in assessing the prognosis of patients diagnosed with chronic heart failure (HF).

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

2 later 510(k) summaries name this device as a predicate

Record

Type
Traditional
Received
Dec 7, 2009
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1117

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.